The board of directors of Sino Biopharmaceutical Limited announced that, Professor Mao Li has been appointed as the Chief Medical Officer by the company. He will be mainly responsible for formulating research and development strategy of innovative products, directing translational research and clinical development for innovative product pipelines, and promoting international collaborations.